Literature DB >> 15045468

Health-related quality of life after osteoporotic fractures.

I Hallberg1, A M Rosenqvist, L Kartous, O Löfman, O Wahlström, G Toss.   

Abstract

OBJECTIVE: To estimate the impact of osteoporosis fractures on health-related quality of life (HRQOL) in postmenopausal women.
METHODS: To compare the impact on HRQOL of different osteoporotic fractures, 600 consecutive women 55-75 years old with a new fracture (inclusion fracture) were invited by mail. After exclusions by preset criteria (high-energy fractures, ongoing osteoporosis treatment, or unwillingness to participate), 303 women were included, 171 (56%) of whom had a forearm, 37 (12%) proximal humerus, 40 (13%) hip, and 55 (18%) vertebral fracture, respectively, and all were investigated and treated according to the current local consensus program for osteoporosis. In addition, HRQOL was evaluated by the SF-36 questionnaire and compared with local, age-matched reference material. Examinations were performed 82 days (median) after the fracture and 2 years later.
RESULTS: HRQOL was significantly reduced at baseline regarding all SF-36 domains after vertebral fractures and most after hip fractures, but only regarding some domains after forearm and humerus fracture. After 2 years, improvements had occurred after all types of fractures, and after forearm or humerus fracture, HRQOL was completely normalized in all domains. However, 2 years after hip fracture, HRQOL was still below normal regarding physical function, role-physical and social function, while after vertebral fracture, scores were still significantly lower for all domains, physical as well as mental. Patients with one or more previous fractures before the inclusion fracture had lower HRQOL at baseline and after 2 years, compared with those with no previous fracture. Patients with osteoporosis (T-score <-2.5 in hip or spine) had lower HRQOL than those with normal BMD.
CONCLUSION: Vertebral and hip fractures have a considerably greater and more prolonged impact on HRQOL than forearm and humerus fractures. The number of fractures was inversely correlated to HRQOL. These differences should be taken into account when making priorities in health care programs.

Entities:  

Mesh:

Year:  2004        PMID: 15045468     DOI: 10.1007/s00198-004-1622-5

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  21 in total

1.  The influence of osteoporotic fractures on health-related quality of life in community-dwelling men and women across Canada.

Authors:  J D Adachi; G Loannidis; C Berger; L Joseph; A Papaioannou; L Pickard; E A Papadimitropoulos; W Hopman; S Poliquin; J C Prior; D A Hanley; W P Olszynski; T Anastassiades; J P Brown; T Murray; S A Jackson; A Tenenhouse
Journal:  Osteoporos Int       Date:  2001       Impact factor: 4.507

2.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

3.  The Swedish SF-36 Health Survey III. Evaluation of criterion-based validity: results from normative population.

Authors:  M Sullivan; J Karlsson
Journal:  J Clin Epidemiol       Date:  1998-11       Impact factor: 6.437

4.  A case-control study of quality of life and functional impairment in women with long-standing vertebral osteoporotic fracture.

Authors:  S E Hall; R A Criddle; T L Comito; R L Prince
Journal:  Osteoporos Int       Date:  1999       Impact factor: 4.507

5.  Has the impact of hormone replacement therapy on health-related quality of life been undervalued?

Authors:  A N Tosteson; S E Gabriel; T S Kneeland; M M Moncur; P D Manganiello; I Schiff; B Ettinger; L J Melton
Journal:  J Womens Health Gend Based Med       Date:  2000-03

6.  Quality of life in patients with vertebral fractures: validation of the Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO). Working Party for Quality of Life of the European Foundation for Osteoporosis.

Authors:  P Lips; C Cooper; D Agnusdei; F Caulin; P Egger; O Johnell; J A Kanis; S Kellingray; A Leplege; U A Liberman; E McCloskey; H Minne; J Reeve; J Y Reginster; M Scholz; C Todd; M C de Vernejoul; I Wiklund
Journal:  Osteoporos Int       Date:  1999       Impact factor: 4.507

7.  The Swedish SF-36 Health Survey--I. Evaluation of data quality, scaling assumptions, reliability and construct validity across general populations in Sweden.

Authors:  M Sullivan; J Karlsson; J E Ware
Journal:  Soc Sci Med       Date:  1995-11       Impact factor: 4.634

Review 8.  Raloxifene: recent information on skeletal and non-skeletal effects.

Authors:  Oscar Gluck; Michael Maricic
Journal:  Curr Opin Rheumatol       Date:  2002-07       Impact factor: 5.006

9.  Functional recovery after fractures of the distal forearm. Analysis of radiographic and other factors affecting the outcome.

Authors:  J P Kaukonen; E O Karaharju; M Porras; P Lüthje; A Jakobsson
Journal:  Ann Chir Gynaecol       Date:  1988

10.  The impact of incident vertebral and non-vertebral fractures on health related quality of life in postmenopausal women.

Authors:  Jonathan D Adachi; George Ioannidis; Wojciech P Olszynski; Jacques P Brown; David A Hanley; Rolf J Sebaldt; Annie Petrie; Alan Tenenhouse; Gregory F Stephenson; Alexandra Papaioannou; Gordon H Guyatt; Charlie H Goldsmith
Journal:  BMC Musculoskelet Disord       Date:  2002-04-22       Impact factor: 2.362

View more
  106 in total

1.  Femoral fractures in the extremely elderly.

Authors:  Giulio Guido; Stefano Giannotti; Vanna Bottai; Marco Ghilardi; Maria Giulia Bianchi; Michael James Ceglia
Journal:  Clin Cases Miner Bone Metab       Date:  2011-05

2.  Quantitative trait loci modulate vertebral morphology and mechanical properties in a population of 18-month-old genetically heterogeneous mice.

Authors:  Grant M Reeves; Barbara R McCreadie; Shu Chen; Andrzej T Galecki; David T Burke; Richard A Miller; Steven A Goldstein
Journal:  Bone       Date:  2006-10-13       Impact factor: 4.398

3.  Cost effectiveness of raloxifene in the treatment of osteoporosis in Sweden: an economic evaluation based on the MORE study.

Authors:  Fredrik Borgström; Olof Johnell; John A Kanis; Anders Oden; David Sykes; Bengt Jönsson
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

4.  Quality of life assessments with SF 36 in different musculoskeletal diseases.

Authors:  Figen Yilmaz; Fusun Sahin; Ernur Ergoz; Emel Deniz; Cem Ercalik; Serap Dalgic Yucel; Banu Kuran
Journal:  Clin Rheumatol       Date:  2007-09-13       Impact factor: 2.980

5.  Risk factors for hip fracture in older home care clients.

Authors:  Paul Stolee; Jeff Poss; Richard J Cook; Kerry Byrne; John P Hirdes
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2009-02-05       Impact factor: 6.053

6.  Longitudinal construct validity of the Health Utilities Indices Mark 2 and Mark 3 in hip fracture.

Authors:  C Allyson Jones; Sheri L Pohar; David H Feeny; Ken Eng
Journal:  Qual Life Res       Date:  2013-10-01       Impact factor: 4.147

Review 7.  Elevated bone mass: a weighty matter?

Authors:  William D Leslie
Journal:  Skeletal Radiol       Date:  2008-12       Impact factor: 2.199

8.  Determinants of health-related quality of life in women with vertebral fractures.

Authors:  Alexandra Papaioannou; Courtney C Kennedy; George Ioannidis; Jacques P Brown; Anjali Pathak; David A Hanley; Robert G Josse; Rolf J Sebaldt; Wojciech P Olszynski; Alan Tenenhouse; Timothy M Murray; Annie Petrie; Charles H Goldsmith; Jonathan D Adachi
Journal:  Osteoporos Int       Date:  2005-12-09       Impact factor: 4.507

9.  Prediction of hip and other osteoporotic fractures from hip geometry in a large clinical cohort.

Authors:  W D Leslie; P S Pahlavan; J F Tsang; L M Lix
Journal:  Osteoporos Int       Date:  2009-02-24       Impact factor: 4.507

10.  Effect of low-intensity back exercise on quality of life and back extensor strength in patients with osteoporosis: a randomized controlled trial.

Authors:  M Hongo; E Itoi; M Sinaki; N Miyakoshi; Y Shimada; S Maekawa; K Okada; Y Mizutani
Journal:  Osteoporos Int       Date:  2007-06-16       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.